Loading company…
NewBiologix develops cell line technologies for gene and cell therapies.
NewBiologix develops DNA integration and cell engineering technologies for gene and cell treatments. Its work includes engineered cells for rAAV production and a sequencing-based bioinformatics platform. Founded in 2022, the company is based in Lausanne, Switzerland. It raised USD 50 million in Series A funding in May 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in